Anand Mahindra shares grab of death certificate portal with two drop-down options, leaves internet amused

-

Business tycoon Anand Mahindra is quite popular on social media for creating a buzz with his witty and insightful posts. This time too, he has grabbed eyeballs on the internet for a bizarre screenshot of a portal that issues death certificates.

The process of availing a death certificate is not something new. To apply for one - a person needs to visit a government website issuing the same, then register or log in and apply for the certificate. But here, the industrialist’s post is about a webpage asking ‘whether you are applying it for yourself or for someone else’.

The post has left social media users confused as to why would a website ask if a person is getting the document (death certificate) for himself.

Taking to Twitter, the CEO of Mahindra Group posted a snapshot of the webpage which is from Mecklenburg County, North Carolina in the United States. In the image, a portal designed for generating death certificates is showing two drop-down options where a user has to specify for whom they were generating the certificate. The drop-down option gave quite an unusual selection, that has left users laughing out loud.

“So we’re not the only culture that believes in an afterlife…” the industrialist quipped while sharing the post on his official handle.

Check the tweet here:

Since it was shared, this post has collected over 24,000 likes and more than 2,500 retweets. Several users came up with their own theories to support the reason. One user commented, “After seeing such things, one has all the right to click 'myself'.” Another wrote, “anticipatory death certificate is the idea here it seems.” Few came up with hilarious reasons while others agreed with Mahindra.

We have no idea what the people of Mecklenburg County believe in, but one may assume that it could be a technical glitch. What do you think?

Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.



from Firstpost India Latest News https://ift.tt/LFm6sw1
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more